|
|
| (11) | Number of the document | C 1651658 |
| (68) | Number of the document | 1651658 |
| (21) | Application number for Supplementary Protection Certificate | PA 2014 008 |
| (22) | Date of filing the application | 2014-02-19 |
| (41) | Date of publication of the application | 2014-04-25 |
| Date of publication of SPC | 2015-07-27 | |
| (24) | Date of coming into effect of SPC | 2024-07-31 |
| (71) |
Mitsubishi Tanabe Pharma Corporation,
2-6-18, Kitahama Chuo-ku Osaka-shi, Osaka 541-8505,
JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka 541-8505,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/13/884/001 - EU/1/13/884/004, 2013- 11-15 EU/1/13/884/005 - EU/1/13/884/008, 2013-11-15 |
| (94) | 2028-11-19 |
| (95) | Canaglifozinum |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 2 | 347.00 EUR |
| 2026-07-31 |
| SPC granted |